SCHEMBL22340862

SCHEMBL22340862

CCCN(Cc1ccc(OC)cc1)c1cccc(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 4/20 0.55
MTNR1B P49286 4/20 0.55
LMNA P02545 3/20 0.46
MAPT P10636 1/20 0.46
CETP P11597 3/20 0.45
TAS2R14 Q9NYV8 1/20 0.45
ALOX15 P16050 1/20 0.44
USP2 O75604 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.43
TSHR P16473 2/20 0.43
CYP2C9 P11712 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
APAF1 O14727 1/20 0.43
NR1I2 O75469 1/20 0.43
HSP90AA1 P07900 1/20 0.43
IDE P14735 1/20 0.43
UBE2N P61088 1/20 0.43
CASR P41180 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20871034 0.92 MTNR1A (0.53) MTNR1AMTNR1BLMNAMAPTCETP
SCHEMBL20871135 0.90 MTNR1A (0.52) MTNR1AMTNR1BLMNAMAPTCETP
SCHEMBL20871418 0.89 MTNR1A (0.51) MTNR1AMTNR1BLMNAMAPTCETP
SCHEMBL20870801 0.89 MTNR1A (0.51) MTNR1AMTNR1BLMNAMAPTCETP
SCHEMBL22340880 0.89 MTNR1A (0.51) MTNR1AMTNR1BLMNAMAPTCETP
SCHEMBL20870836 0.89 MTNR1A (0.51) MTNR1AMTNR1BLMNAMAPTCETP
SCHEMBL22340523 0.88 MTNR1A (0.51) MTNR1AMTNR1BLMNAMAPTCETP
SCHEMBL20871451 0.86 CNR2 (0.53) MTNR1AMTNR1BLMNAMAPTTAS2R14
SCHEMBL12219826 0.86 MTNR1A (0.54) MTNR1AMTNR1BALOX15
SCHEMBL20871185 0.85 QPCT (0.50) MTNR1AMTNR1BCETPTSHRCALM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3707132-B1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES UNIV PARIS SACLAY (FR) 2024-07-17 EP disclosed
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines Universite Paris-Saclay (FR) 2021-06-15 US disclosed
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES Universite Paris-Saclay (FR) 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES ADH1C, ADH1A, ADH5 MTNR1A 1729/4885MTNR1B 1788/4885LMNA 944/4885
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines ADH1C, PNMT, ADH1A MTNR1A 2113/4885MTNR1B 2187/4885LMNA 1096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.